|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 38/17 | (2013.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 37/00 | (2018.01) | ||
| A61K 38/1767 | (2013.01) |
| (11) | Number of the document | 3151851 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15728491.0 |
| Date of filing the European patent application | 2015-06-08 | |
| (97) | Date of publication of the European application | 2017-04-12 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/062742 |
| Date | 2015-06-08 |
| (87) | Number | WO 2015/185760 |
| Date | 2015-12-10 |
| (30) | Number | Date | Country code |
| 201410116 | 2014-06-06 | GB |
| (72) |
WESTON-DAVIES, Wynne H , GB
|
| (73) |
Volution Immuno Pharmaceuticals SA ,
Place Des Eaux Vives 6,, 3461-1211 Geneve 3,
CH
|
| (54) | ORNITHODOROS MOUBATA COMPLEMENT INHIBITOR FOR USE IN THE TREATMENT OF COMPLEMENT-MEDIATED DISEASES IN PATIENTS WITH C5 POLYMORPHISM |
| ORNITHODOROS MOUBATA COMPLEMENT INHIBITOR FOR USE IN THE TREATMENT OF COMPLEMENT-MEDIATED DISEASES IN PATIENTS WITH C5 POLYMORPHISM |